Live Blog

MARKET WRAP: RIL, HDFC Bank help Sensex settle 466 pts higher; pharma slips

All that happened in the markets today

SI Reporter New Delhi
stock market
NSE's Nifty ended at 10,764, up 156 points or 1.47 per cent (Photo: Kamlesh Pednekar)

3 min read Last Updated : Jul 06 2020 | 4:15 PM IST

4:15 PM

MARKET QUOTE:: Vinod Nair, Head of Research at Geojit Financial Services

Indian indices ended with gains, in sync with solid global cues. Global markets rallied on hopes of a faster Chinese economic revival which could provide support to the global economy. The positivity regarding the recovery is extending to Indian markets also, in spite of surging infections, along with liquidity. The first signs of de-escalation of India –China border tensions should also calm the markets. We maintain the sell-on-rise strategy and advise investors to trade with caution.

3:44 PM

SECTOR WATCH:: Barring Nifty Pharma, all sectoral indices on the NSE end in the green

3:42 PM

MARKET AT CLOSE:: Gainers and losers on the S&P BSE Sensex

3:35 PM

CLOSING BELL

The S&P BSE Sensex rallied 466 points or 1.29 per cent to settle at 36,487 while NSE's Nifty ended at 10,764, up 156 points or 1.47 per cent. 

3:28 PM

MARKET CHECK

3:20 PM

INDEX GAINER:: Bajaj Finance advances 6.7%

3:09 PM

RIL, HDFC Bank contribute the most to the S&P BSE Sensex's gain today

3:01 PM

Performance may be quite volatile in FY21 due to coronavirus: Dr Reddy's

Sharing information with the company's shareholders, the drug major said overall, there was no major impact of the pandemic during the last fiscal, including the fourth quarter.
 
"Having said so, we believe FY2021 will have more uncertainties than ever before. Consequently, our overall performance may be quite volatile," Dr Reddy's Laboratories said. READ MORE

2:58 PM

ALERT :: Dow Jones Futures climb 300 pts

2:52 PM

Marico declines 4% on profit-booking post June quarter business update

Shares of Marico slipped 4 per cent to Rs 344 in intra-day trade on the BSE on Monday on profit-booking after the company said it has seen a 13-15 per cent decline in revenues for the quarter ended June 2020 (Q1FY20-21). The Q1 contributes 31 per cent to revenues. In an update on quarterly performance, Marico said with the Q1 top-line translating into a single-digit growth over the annual run rate of FY20, the company expects to bounce back to posting volume and value growth during the rest of the year. READ MORE

2:48 PM

Covid-19 may turn extra Rs 1.67 trn debt into delinquent assets: Ind-Ra

Given that 11.57 per cent of the outstanding debt is already stressed, the proportion of stressed debt is likely to rise to 18.21 per cent of the outstanding quantum. Ind-Ra expects the corresponding credit cost, money set aside as provision for bad loans, to be 3.57 per cent of the total debt.
 
The rating agency said it has analysed the degree of vulnerability of the top-500 debt-heavy private sector issuers, after assessing the mix between productive and non-productive assets held by each issuer along with their refinancing risks. READ MORE

2:46 PM

BROKERAGE VIEW :: Emkay on Equitas Holdings

We retain our Buy rating with a revised target price of Rs65 (up from Rs54), based on 0.7x FY22 ABV, given better deposit traction after a scare across SFBs in Q4, which should help the bank in the long run to protect its margins/RoA. However, asset quality performance and listing its SFB will remain key monitorable in the near term.

2:46 PM

BROKERAGE VIEW :: Emkay on Motherson Sumi

The restructuring exercise proposes to create a separate entity for the domestic wiring harness business (new company DWH), and a merger of parent entity SAMIL into MSS to bring in the remaining 49% SMR PBV stake and other auto/non-auto businesses.
 
The proposed share swap implies a valuation of ~Rs244bn for SAMIL. The transaction would be EPS dilutive on our estimates, and to be EPS accretive by FY22E, a strong turnaround would be needed in SMR PBV and SAIML’s auto/non-auto businesses.
 
A shift to this new platform is a step toward the company’s Vision 2025 – revenue target of $33-35bn with ROCE of 40%. Retain Buy with a target price of Rs 115, based on 20x FY22E EPS.

2:44 PM

BROKERAGE VIEW :: Nomura on gas transmission companies

With a sharp decline in transmission volume, we expect post-tax ROCE for the pipeline business to fall to just ~6% for FY21-22F (vs 12% as per regulation). Further, we expect the petchem segment to remain in losses over FY21-22F. We reiterate our Reduce rating on GAIL with target price of Rs 85. Indraprastha Gas [Buy, target: Rs 575] is our preferred gas name.

2:42 PM

BROKERAGE VIEW :: ICICI Securities on Sobha Developers

Sobha’s net debt reduced marginally in Q1FY21 for the second consecutive quarter. We have built in FY21/22E volumes of 2.7msf and 3.6msf respectively, vs. annual run rate of 4msf to reflect the slowdown. We retain our BUY rating with a SOTP based target price of Rs261/share. Ability to keep debt levels in check remains the key monitorable.

Topics :CoronavirusMarketsHDFC BankICICI Bank MARKET WRAP

First Published: Jul 06 2020 | 7:23 AM IST